First reported 18 hours ago -
Updated 18 hours ago -
F. Hoffmann-La Roche Ltd has received approval from the European Commission, or EU, for the use of Avastin in combination with paclitaxel
, topotecan, or pegylated liposomal doxorubicin chemotherapy as a treatment for women with recurrent ovarian cancer ...
[Published Individual.com - 18 hours ago]